Fortress Biotech, Inc. Forecast, price target & analysts
Fortress Biotech, Inc. Target price 2025 - Analyst rating & recommendation
Fortress Biotech, Inc. Classifications & Recommendation:
Fortress Biotech, Inc. Price Target
| Target Price | $10.00 |
| Price | $1.54 |
| Potential |
549.35%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Fortress Biotech, Inc. 2026 .
The average Fortress Biotech, Inc. target price is $10.00.
This is
549.35%
register free of charge
$16.00
938.96%
register free of charge
$4.00
159.74%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend Fortress Biotech, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Fortress Biotech, Inc. stock has an average upside potential 2026 of
549.35%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 84.51 | 57.13 |
| 11.58% | 32.39% | |
| EBITDA Margin | -155.21% | -185.36% |
| 39.47% | 19.42% | |
| Net Margin | -276.42% | -169.28% |
| 48.04% | 38.76% |
3 Analysts have issued a sales forecast Fortress Biotech, Inc. 2024 . The average Fortress Biotech, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Fortress Biotech, Inc. 2024 . The average Fortress Biotech, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2023 | $-131m | 32.46% |
|---|---|---|
| 2024 |
$-106m
19.27%
Unlock
|
|
EBITDA Margin
| 2023 | -155.21% | 39.47% |
|---|---|---|
| 2024 |
-185.36%
19.42%
Unlock
|
|
3 Fortress Biotech, Inc. Analysts have issued a net profit forecast 2024. The average Fortress Biotech, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -8.47 | -3.51 |
| 42.03% | 58.56% | |
| P/E | negative | |
| EV/Sales | 0.41 |
3 Analysts have issued a Fortress Biotech, Inc. forecast for earnings per share. The average Fortress Biotech, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Fortress Biotech, Inc....
Current Fortress Biotech, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Roth MKM |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Roth MKM:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 18 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
